Prognostics
Clinical factors used to select patients who would benefit from hepatic metastasectomy
Published in Women's Health Weekly, April 10th, 2006
"Hepatic metastases from breast cancer signal a dismal prognosis, with a median survival of 9.5 months. Twenty breast cancer patients with liver metastases underwent hepatic resection, biopsy, or ablation between 1995 and 2004. Hormone receptor status and Her-2/neu expression of primary and metastatic tumors were correlated with overall survival," scientists in the United States reported.
"At a mean follow-up of 39 months after hepatic resection, median survival was 32 months. Patients undergoing anatomic resection...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Breast cancer treatment disparities may exist due to ethnicity and insurance status - Colon Cancer
Colon cancer risk may be associated with central adiposity in women - Hypertension
Hypertension may be adversely affected by swimming therapy in older women - Ischemia
Myocardial perfusion is improved by tibolone therapy in women with ischemic heart disease - Obesity Research
Obesity risk in women may be related to socioeconomic status in childhood - Apoptosis
Estrogen induction protects cells from mediated apoptosis - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
